Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Controlled Randomized Study of the Efficacy and Safety of Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts (Phase III)

NCT05156541 is registered in ClinicalTrials.gov with SPP Pharmaclon Ltd. as lead sponsor.

NCT NCT05156541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05156541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Controlled Randomized Study of the Efficacy and Safety of Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts (Phase III)
Lead sponsor
SPP Pharmaclon Ltd.
Phase
Phase 3
Overall status
Completed
Start date
May 18, 2009
Completion date
July 15, 2010
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anogenital warts, human papillomavirus infection